FDA Adverse Event Malfunction Summary report: N

COLONOVIDEOSCOPE

MDR report key: 22283843 · Received June 18, 2025

Report

Report Number
9610595-2025-11561
Event Type
Malfunction
Date Received
June 18, 2025
Date of Event
May 23, 2025
Report Date
June 18, 2025
Manufacturer
AIZU OLYMPUS CO., LTD.
Product Code
FDF
PMA / PMN Number
K222584
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
GM
Reporter Occupation
003

Narratives

Additional Manufacturer Narrative · 0

THE DEVICE WAS RETURNED TO OLYMPUS FOR INSPECTION. ACCORDING TO PREVIOUS INVESTIGATIONS, THE USE OF PRODUCTS THAT CONTAIN SILICONE CAN CAUSE DEPOSITS OF WHITE FOREIGN MATERIAL. SILICONE IS FOR EXAMPLE INCLUDED IN SIMETHICONE, A DEFOAMING AGENT, LUBRICANTS AND SO ON. IF THE CUSTOMER USED THEM, THERE WAS RISK THAT FOREIGN MATERIAL REMAINED IN THE CHANNEL EVEN IF THE REPROCESSING WAS CONDUCTED IN ACCORDANCE WITH IFU. SIMETHICONE AND PETROLEUM/OIL/SILICONE-BASED LUBRICANTS ARE NON-WATER SOLUBLE AND THUS NOT RECOMMENDED FOR USE BY OLYMPUS. THE MOST PROBABLE CAUSE OF THE FAILURES "AW-CYLINDER (TUBE) HAS WHITE FOREIGN OBJECTS", "AW-TUBE HAS WHITE FOREIGN OBJECTS" AND "JET TUBE HAS WHITE FOREIGN OBJECTS" IS KNOWN INHERENT RISK OF DEVICE. THE EVENT CAN BE DETECTED/PREVENTED BY FOLLOWING THE INSTRUCTIONS FOR USE WHICH STATE: ¿NOTHING OTHER THAN STERILE WATER SHOULD BE USED FOR AIR/WATER FEEDING. NO ADDITIVES SHOULD BE PUT INTO THE STERILE WATER. NON-STERILE WATER MAY CAUSE PATIENT CROSS-CONTAMINATION AND/OR INFECTION.¿ SHOULD ADDITIONAL RELEVANT INFORMATION BECOME AVAILABLE, A SUPPLEMENTAL REPORT WILL BE SUBMITTED. OLYMPUS WILL CONTINUE TO MONITOR FIELD PERFORMANCE FOR THIS DEVICE.

Description of Event or Problem · 0

IT WAS OBSERVED THAT DURING THE DEVICE EVALUATION, THE SUBJECT DEVICE EXHIBITED WHITE FOREIGN MATERIALS IN AIR/WATER CYLINDER, AIR/WATER TUBE AND IN AUXILIARY JET CHANNEL. THERE WAS NO PATIENT INVOLVEMENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1639728 COLONOVIDEOSCOPE COLONOVIDEOSCOPE FDF AIZU OLYMPUS CO., LTD. CF-HQ1100DL

Patients

Seq Age Sex Outcome Treatment
1 NA Unknown